Expert Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 16-11-2024
- Paid Up Capital ₹ 1.00 Cr
as on 16-11-2024
- Company Age 11 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 16.77 Cr
as on 16-11-2024
- Satisfied Charges ₹ 5.25 Cr
as on 16-11-2024
- Revenue -13.70%
(FY 2023)
- Profit -154.25%
(FY 2023)
- Ebitda -60.28%
(FY 2023)
- Net Worth -5.01%
(FY 2023)
- Total Assets -6.50%
(FY 2023)
About Expert Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 1.00 Cr.
The company currently has active open charges totaling ₹16.77 Cr. The company has closed loans amounting to ₹5.25 Cr, as per Ministry of Corporate Affairs (MCA) records.
Ketanbhai Khambhatta and Vinitbhai Khambhatta serve as directors at the Company.
- CIN/LLPIN
U24230GJ2013PTC076677
- Company No.
076677
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
03 Sep 2013
- Date of AGM
28 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Expert Pharmaceuticals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ketanbhai Khambhatta  | Director | 03-Sep-2013 | Current |
| Vinitbhai Khambhatta | Director | 03-Sep-2013 | Current |
Financial Performance and Corporate Structure Insights of Expert Pharmaceuticals.
Expert Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 13.7% decrease. The company also saw a substantial fall in profitability, with a 154.25% decrease in profit. The company's net worth dipped by a decrease of 5.01%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Expert Pharmaceuticals?
In 2023, Expert Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Kevin Technologies Private LimitedActive 24 years 6 monthsKetanbhai Khambhatta and Vinitbhai Khambhatta are mutual person
Kambert Machinery Company Private LimitedActive 22 years 5 monthsKetanbhai Khambhatta and Vinitbhai Khambhatta are mutual person
Cadmach Machinery Company Private LimitedActive 51 years 3 monthsKetanbhai Khambhatta and Vinitbhai Khambhatta are mutual person
Kevin Process Technologies Private LimitedActive 29 years 6 monthsKetanbhai Khambhatta and Vinitbhai Khambhatta are mutual person
Kevision Systems Private LimitedActive 10 months 27 daysKetanbhai Khambhatta and Vinitbhai Khambhatta are mutual person
- Vac-U-Max Asia Private LimitedActive 25 years 6 months
Ketanbhai Khambhatta and Vinitbhai Khambhatta are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 01 Aug 2023 | ₹2.80 M | Open |
Others Creation Date: 17 Feb 2016 | ₹16.49 Cr | Open |
Vijaya Bank Creation Date: 12 Dec 2014 | ₹5.25 Cr | Satisfied |
How Many Employees Work at Expert Pharmaceuticals?
Expert Pharmaceuticals has a workforce of 64 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Expert Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Expert Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
